Literature DB >> 16891478

Multicenter comparison of nucleic acid extraction methods for detection of severe acute respiratory syndrome coronavirus RNA in stool specimens.

A Petrich1, J Mahony, S Chong, G Broukhanski, F Gharabaghi, G Johnson, L Louie, K Luinstra, B Willey, P Akhaven, L Chui, F Jamieson, M Louie, T Mazzulli, R Tellier, M Smieja, W Cai, M Chernesky, S E Richardson.   

Abstract

The emergence of a novel coronavirus (CoV) as the cause of severe acute respiratory syndrome (SARS) catalyzed the development of rapid diagnostic tests. Stool samples have been shown to be appropriate for diagnostic testing for SARS CoV, although it has been recognized to be a heterogeneous and difficult sample that contains amplification inhibitors. Limited information on the efficiency of extraction methods for the purification and concentration of SARS CoV RNA from stool samples is available. Our study objectives were to determine the optimal extraction method for SARS CoV RNA detection and to examine the effect of increased specimen volume for the detection of SARS CoV RNA in stool specimens. We conducted a multicenter evaluation of four automated and four manual extraction methods using dilutions of viral lysate in replicate mock stool samples, followed by quantitation of SARS CoV RNA using real-time reverse transcriptase PCR. The sensitivities of the manual methods ranged from 50% to 100%, with the Cortex Biochem Magazorb method, a magnetic bead isolation method, allowing detection of all 12 positive samples. The sensitivities of the automated methods ranged from 75% to 100%. The bioMérieux NucliSens automated extractor and miniMag extraction methods each had a sensitivity of 100%. Examination of the copy numbers detected and the generation of 10-fold dilutions of the extracted material indicated that a number of extraction methods retained inhibitory substances that prevented optimal amplification. Increasing the volume of sample input did improve detection. This information could be useful for the extraction of other RNA viruses from stool samples and demonstrates the need to evaluate extraction methods for different specimen types.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16891478      PMCID: PMC1594626          DOI: 10.1128/JCM.02460-05

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  12 in total

1.  Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens.

Authors:  M Smieja; J B Mahony; C H Goldsmith; S Chong; A Petrich; M Chernesky
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories.

Authors:  Max Chernesky; Marek Smieja; Julius Schachter; James Summersgill; Laura Schindler; Natalie Solomon; Karen Campbell; LeeAnn Campbell; Alison Cappuccio; Charlotte Gaydos; Sylvia Chong; Jeanne Moncada; Jack Phillips; Dan Jang; Billie Jo Wood; Astrid Petrich; Margaret Hammerschlag; Mike Cerney; James Mahony
Journal:  J Clin Microbiol       Date:  2002-07       Impact factor: 5.948

3.  Comprehensive PCR-based assay for detection and species identification of human herpesviruses.

Authors:  G Johnson; S Nelson; M Petric; R Tellier
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Complex polysaccharides as PCR inhibitors in feces: Helicobacter pylori model.

Authors:  L Monteiro; D Bonnemaison; A Vekris; K G Petry; J Bonnet; R Vidal; J Cabrita; F Mégraud
Journal:  J Clin Microbiol       Date:  1997-04       Impact factor: 5.948

5.  Removal of inhibitory substances from human fecal specimens for detection of group A rotaviruses by reverse transcriptase and polymerase chain reactions.

Authors:  J Wilde; J Eiden; R Yolken
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

6.  Performance and Cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-pcr assays for detection of severe acute respiratory syndrome coronavirus.

Authors:  James B Mahony; Astrid Petrich; Lisa Louie; Xinyu Song; Sylvia Chong; Marek Smieja; Max Chernesky; Mark Loeb; Susan Richardson
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

7.  Detection and monitoring of SARS coronavirus in the plasma and peripheral blood lymphocytes of patients with severe acute respiratory syndrome.

Authors:  Haibin Wang; Yuanli Mao; Liancai Ju; Jing Zhang; Zhiguo Liu; Xianzhi Zhou; Qinghong Li; Yuedong Wang; Sunghee Kim; Lurong Zhang
Journal:  Clin Chem       Date:  2004-07       Impact factor: 8.327

8.  Laboratory diagnosis of SARS.

Authors:  Paul K S Chan; Wing-Kin To; King-Cheung Ng; Rebecca K Y Lam; Tak-Keung Ng; Rickjason C W Chan; Alan Wu; Wai-Cho Yu; Nelson Lee; David S C Hui; Sik-To Lai; Ellis K L Hon; Chi-Kong Li; Joseph J Y Sung; John S Tam
Journal:  Emerg Infect Dis       Date:  2004-05       Impact factor: 6.883

9.  Early diagnosis of SARS coronavirus infection by real time RT-PCR.

Authors:  Leo L M Poon; Kwok Hung Chan; On Kei Wong; Wing Cheong Yam; Kwok Yung Yuen; Yi Guan; Y M Dennis Lo; Joseph S M Peiris
Journal:  J Clin Virol       Date:  2003-12       Impact factor: 3.168

10.  Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection.

Authors:  Wai K Leung; Ka-Fai To; Paul K S Chan; Henry L Y Chan; Alan K L Wu; Nelson Lee; Kwok Y Yuen; Joseph J Y Sung
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

View more
  23 in total

1.  Comparison of automated nucleic acid extraction methods with manual extraction.

Authors:  Nicola Dundas; N Kristine Leos; Midori Mitui; Paula Revell; Beverly Barton Rogers
Journal:  J Mol Diagn       Date:  2008-06-13       Impact factor: 5.568

2.  Detection of severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in human serum using a localized surface plasmon coupled fluorescence fiber-optic biosensor.

Authors:  Jason C Huang; Ying-Feng Chang; Kuan-Hsuan Chen; Li-Chen Su; Chun-Wei Lee; Chii-Chang Chen; Yi-Ming Arthur Chen; Chien Chou
Journal:  Biosens Bioelectron       Date:  2009-07-17       Impact factor: 10.618

3.  High-throughput direct fecal PCR assay for detection of Mycobacterium avium subsp. paratuberculosis in sheep and cattle.

Authors:  Karren M Plain; Ian B Marsh; Anna M Waldron; Francesca Galea; Ann-Michele Whittington; Vanessa F Saunders; Douglas J Begg; Kumudika de Silva; Auriol C Purdie; Richard J Whittington
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

Review 4.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

5.  Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays.

Authors:  Jie He; Andrea J Kraft; Jiang Fan; Meredith Van Dyke; Lihua Wang; Michael E Bose; Marilyn Khanna; Jacob A Metallo; Kelly J Henrickson
Journal:  Viruses       Date:  2009       Impact factor: 5.048

6.  Clinical evaluation of NucliSENS magnetic extraction and NucliSENS analyte-specific reagents for real-time detection of human metapneumovirus in pediatric respiratory specimens.

Authors:  Christine C Ginocchio; Ryhana Manji; Madhavi Lotlikar; Fan Zhang
Journal:  J Clin Microbiol       Date:  2008-02-13       Impact factor: 5.948

7.  Multicenter comparative evaluation of five commercial methods for toxoplasma DNA extraction from amniotic fluid.

Authors:  H Yera; D Filisetti; P Bastien; T Ancelle; P Thulliez; L Delhaes
Journal:  J Clin Microbiol       Date:  2009-10-21       Impact factor: 5.948

8.  Performance evaluation of the Maxwell 16 System for extraction of influenza virus RNA from diverse samples.

Authors:  Hongbo Liu; Yan Gan; Bo Yang; Hui Weng; Chunmei Huang; Daofeng Yang; Ping Lei; Guanxin Shen
Journal:  PLoS One       Date:  2012-10-29       Impact factor: 3.240

9.  Synthetic long oligonucleotides to generate artificial templates for use as positive controls in molecular assays: drug resistance mutations in influenza virus as an example.

Authors:  Bin Wang; Megan C Steain; Dominic E Dwyer; Anthony L Cunningham; Nitin K Saksena
Journal:  Virol J       Date:  2011-08-16       Impact factor: 4.099

10.  Evaluation of four different systems for extraction of RNA from stool suspensions using MS-2 coliphage as an exogenous control for RT-PCR inhibition.

Authors:  Lester M Shulman; Musa Hindiyeh; Khitam Muhsen; Dani Cohen; Ella Mendelson; Danit Sofer
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.